Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ASND

Ascendis Pharma A/S

May 27 • 12:45PM ET

237.74

-1.90 -0.79 %

Healthcare • Biotechnology • Denmark • Large • NASD

Peers: BMRN SRPT INSM RYTM ALNY IONS KRYS UTHR FOLD VKTX

| Held by: TCAF IBB SPDW FDG AFOS QQQJ MSSM MEDI TMSL ONEQ

Scroll to Statements

Index	-	P/E	26.79	EPS (ttm)	8.87	Insider Own	0.89%	Shs Outstand	62.11M	Perf Week	-0.10%
Market Cap	14.77B	Forward P/E	21.83	EPS next Y	10.89	Insider Trans	-3.40%	Shs Float	61.56M	Perf Month	4.89%
Enterprise Value	15.14B	PEG	-	EPS next Q	1.82	Inst Own	107.99%	Short Float	4.60%	Perf Quarter	4.27%
Income	581.90M	P/S	14.69	EPS this Y	455.56%	Inst Trans	-48.39%	Short Ratio	4.26	Perf Half Y	12.95%
Sales	1.01B	P/B	26.26	EPS next Y	-29.98%	ROA	33.69%	Short Interest	2.83M	Perf YTD	11.49%
Book/sh	9.05	P/C	22.37	EPS next 5Y	-	ROE	325.80%	52W High	250.74 -5.18%	Perf Year	51.17%
Cash/sh	10.63	P/FCF	292.00	EPS past 3/5Y	27.03% 14.76%	ROIC	57.78%	52W Low	156.56 51.86%	Perf 3Y	164.90%
Dividend Est.	-	EV/EBITDA	1120.61	Sales past 3/5Y	147.23% 152.45%	Gross Margin	87.35%	Volatility	3.40% 4.04%	Perf 5Y	74.57%
Dividend TTM	-	EV/Sales	15.06	EPS Y/Y TTM	249.36%	Oper. Margin	-0.66%	ATR (14)	8.91	Perf 10Y	1599.39%
Dividend Ex-Date	-	Quick Ratio	0.72	Sales Y/Y TTM	155.14%	Profit Margin	57.88%	RSI (14)	50.21	Recom	1.05
Dividend Gr. 3/5Y	- -	Current Ratio	1.00	EPS Q/Q	787.72%	SMA20	0.31%	Beta	0.41	Target Price	294.34
Payout	-	Debt/Eq	1.84	Sales Q/Q	171.53%	SMA50	2.07%	Rel Volume	0.54	Prev Close	239.65
Employees	-	LT Debt/Eq	0.79	Earnings	May 07 BMO	SMA200	10.18%	Avg Volume	664.41K	Price	237.74
IPO	Jan 28, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	5921.98% -7.60%	Trades		Volume	189,405	Change	-0.79%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)